The case for universal Hepatitis B screening in China
The current screening program is limited to key target populations including pregnant women, newborn infants, and blood donors.
By
The current screening program is limited to key target populations including pregnant women, newborn infants, and blood donors.
ByIn the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China), GlobalData epidemiologists found that…
ByAre there different investigator skillsets involved in running the varied stages of oncology trials?
ByNew research suggests long delays to bipolar disorder diagnosis, which may increase the burden the condition causes individuals.
ByTop NASH investigator Rohit Loomba discusses the potential of imaging in replacing biopsies, and much more.
ByAs AI and machine learning continues to evolve, we look at how it has impacted healthcare in 2021.
ByA new novel blood test called the Stockholm3test could boost the prostate cancer screening process and help reduce cost and…
ByAlternative treatment options for recurrent and metastatic cervical cancer can transform the landscape and satisfy unmet needs.
By